Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry.
Joint bone spine(2021)
摘要
•Disparities are observed in anti-TNF biosimilar prescriptions across countries.•In the French ART-SFR registry, anti-TNF biosimilar were prescribed in>90% of RA.•Important geographic/centre disparities in biosimilar prescriptions were observed.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要